The following table provides an overview of the latest patents of Salix Pharmaceuticals, Ltd. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3628319Feb 14, 2024Methods Of Treating Hepatic Encephalopathy Using Rifaximin6
EP2350096Dec 11, 2019Methods Of Treating Hepatic Encephalopathy8
EP2252148Mar 20, 2019Methods For Treating Bowel Diseases3